| Meet the University of Wisconsin-Madison’s Adel Talaat Professor of Microbiology, Department of Pathobiological Sciences |
 |
Research area Understanding the pathogenesis and control of emerging infectious diseases and developing new technologies and innovative vaccines against human tuberculosis, avian influenza and paratuberculosis. Research also uses nanotechnology to develop effective nanovaccines against several coronaviruses (avian infectious bronchitis virus and Human SARS-CoV-2).
What excites you about your work?
“What excites me is that we can find solutions for current existing problems by vaccinating animals and humans, and the knowledge we are generating hopefully will be helpful in advancing vaccine development and finding cures for illnesses that should be avoidable. At this day and age, we should be able to control animal and human infections, and I hope my work will provide help toward meeting this measurable goal.”
What do you hope to achieve?
“We hope to get the vaccines we’re working on to the market. I think it will be a big endeavor, but with collaboration between industry, academia, government and VC funding, we will be able to get our vaccines to the market. That would be a highlight of my career.”
Through these diverse research areas, Prof. Talaat’s work contributes significantly to the understanding of infectious diseases and the development of novel approaches to combat them. These are complex scientific challenges that also involve extensive development and regulatory processes. He has shown a tireless determination to enlist the right group or person to help address every obstacle along the way, and we are excited to support his efforts!
– Emily Bauer, WARF, Director of Licensing
Want to learn more?
Emily Bauer, [email protected], 608.960.9842